Email Updates

Search form

You are here

28 JUNE 2019 VOLUME 20 ISSUE 25

Media Coverage

  • The social marketing campaign “PrEP4Love” successfully raised awareness of Truvada as PrEP (pre-exposure prophylaxis) as an HIV-prevention tactic, according to the results of a recent study conducted by the Chicago Center for HIV Elimination (CCHE), reports the AIDS Foundation of Chicago. Specifically, in the campaign’s first four months, the “PrEP4Love” ads garnered nearly 41 million unique views across social media platforms and 25,000 click-throughs.

    June 28, 2019
    POZ
  • A number of universities are rolling out critical antiretroviral therapy (ART) medication to their students living with HIV. This means students don’t have to travel far, spend money, miss classes or face the stigma that comes with going off campus for the life-saving treatment. “We usually see low numbers of people, especially young people, being able to stay on treatment. One of the reasons for this is inaccessibility of clinics that provide ART. Having ART provided on campus means that students would not have to miss a day of school waiting at the clinic for their treatment, they can just go in between classes. Students will also not have to spend on transport.” said Thuthukile Mbatha, a researcher at the nonprofit organisation, Section27.

    June 27, 2019
    Mail & Guardian
  • The approval of the Gardasil human papillomavirus (HPV) vaccine for girls and young women in 2006 has been followed by a dramatic decrease in the prevalence of the four strains of the virus that the vaccine prevents. A newer version of the vaccine that protects against nine HPV types is now approved for both males and females up to age 45.

    June 27, 2019
    POZ
  • According to a new international poll, the United States is now seen as less likely to use its influence for good than it was 10 years ago. While presidential candidates have only begun to lay out their priorities for U.S. foreign policy, reaffirming positive American leadership in the world will be a crucial task for the next U.S. President.

    June 27, 2019
    General
    The Hill
  • In a letter released Thursday, Rep. Elijah E. Cummings (D-Md.) demanded emails and other information from Gilead about negotiations that led to Gilead’s pledge to donate free doses of the drug for President Trump’s effort to eradicate HIV by 2030. Cummings also asked Gilead for details of contact with the Centers for Disease Control and Prevention and other agencies over its claim that U.S. government patents are invalid for Truvada for PrEP, as the preventive use is known.

    June 27, 2019
    Washington Post
  • Vaccines against the human papillomavirus have sharply reduced infections, genital and anal warts, and precancerous lesions in young women and girls in more than a dozen wealthy countries, a major new study has found — powerful evidence that these vaccines will ultimately cause major drops in cervical cancer.

    June 27, 2019
    New York Times
  • Kenyans in remote areas will get the results of their HIV viral load tests within 70 minutes after the approval of a portable point of care testing kit by the World Health Organisation. Previously, the samples would be collected and taken to the Kenya Medical Research Institute and results sent back in two weeks.

    June 26, 2019
    General
    The Star
  • The debate on depo-provera increasing the risk of HIV acquisition started in 1996 when scientists discovered that monkeys injected with high concentration levels of depo-provera also known as DMPA by scientists had their biological make-up weakening, thereby allowing easy penetration of SIV, an equivalent of HIV in humans, into their system.

    June 25, 2019
    The Herald
  • HIV cases are surging in Huntington, West Virginia, a city already ravaged by the opioid epidemic. Experts worry that the virus could proliferate farther still—particularly since Charleston, the state capital an hour away, shut down its syringe exchange last year. The move restricted access not only to clean needles but to HIV testing as well.

    June 25, 2019
    General
    Mother Jones
  • When Cyclone Idai hit Mozambique’s coastal city of Beira in March, heavy winds and torrential rain tore off roofs and destroyed buildings across the city. Many of the city’s residents, particularly those in informal settlements, were forced to flee their homes in search of shelter.

    June 25, 2019
    General
    Devex
  • In December 2018, at an event in Pyongyang marking World AIDS Day, government officials and World Health Organization (WHO) staff celebrated an improbable feat: a corner of our planet was still untouched by HIV. North Korea had zero reported cases of HIV infection, said physician Thushara Fernando—at least to his knowledge. Fernando, who was then WHO’s representative to North Korea, chalked up that astounding success to prevention and widespread HIV testing.

    June 25, 2019
    General
    Science
  • In high-income countries like the U.S., the standard of care for people infected with HIV is to provide antiretroviral pills when the virus is found, even when there are no symptoms of AIDS. The strategy staves off the disease and has a second — big — benefit. It has been shown to prevent the spread of HIV in sexual encounters. It's called "treatment as prevention" (TasP in medical jargon), or "test and treat." But in low-income countries, "test and treat" is not the typical approach to prevention. There has been no research to support it.

    June 24, 2019
    NPR
  • Unfortunately, as mainstream sexual health campaigns about HIV prevention often solely feature white or gay men, in addition to black women not knowing enough about PrEP to protect themselves, those who may be at risk tend to believe they are not.

    June 24, 2019
    Independent
  • Twenty years ago, thousands of Africans died of AIDS each day as pharmaceutical companies looked on, murmuring sympathy but claiming that they could not afford to cut the prices of their $15,000-a-year HIV drugs.

    June 24, 2019
    New York Times
  • The Ministry of Health and Social Services together with the U.S President’s Emergency Plan for AIDS Relief (PEPFAR) have circumcised 150 000 male Namibians since 2009. This milestone was celebrated last Thursday.

    June 24, 2019
    New Era
  • The HIV Vaccine Trials Network (HVTN) has announced it has fully enrolled its four ongoing large-scale HIV vaccine efficacy trials. The clinical trials, under way in 12 countries on four continents, are made possible by 12 669 study participants and the collaborative efforts of HVTN study teams, all on a journey to find a safe and effective HIV vaccine.

    June 24, 2019
    IOL
  • It is seven years since PrEP (pre-exposure prophylaxis) – the drug taken by HIV-negative people that prevents HIV acquisition – was licensed for use in the USA. It is three years since NAT successfully challenged NHS England in the courts on its refusal to consider making PrEP available.

    June 22, 2019
    Huffington Post UK

Published Research

Announcements

  • There will be no issue next week. The NewsDigest will return on July 12, 2019. Happy Independence Day to those celebrating and a wonderful week to all!

    June 28, 2019